Atlantic tarpon Megalops atlanticus are important mesopredators in the western Atlantic Ocean, and the focus of a popular recreational fishery that targets them throughout their annual migration in the Gulf of Mexico and southeastern USA. Using 4 years of acoustic telemetry data, we quantified the seasonal variation in phenology of arrival and departure, and occupancy for subadult and adult M. atlanticus in the Florida Keys, USA. While detection profiles of subadult M. atlanticus (n = 11) varied in residency and dispersal patterns, all adult M. atlanticus detection profiles (n = 47) exhibited seasonal residency. The median spring-summer residence period of adult M. atlanticus ranged from 40 to 60 d, with a mean of 51 d across years. At the individual level, repeatability in the timing of arrival and duration were high across years, suggesting that photoperiod may be an important migratory cue. Further, the repeatability in the timing of arrival to the Florida Keys for individuals was not associated with sea surface temperature (SST). At the population level, residency corresponded with the spawning season, with the majority of adult M. atlanticus arriving in April once SST reached 26°C, and then departing in June (27-29°C). Highest occupancy probabilities for adult M. atlanticus occurred in May (26-28°C) and lowest between August and October. Large aggregations of M. atlanticus that occur during the spawning season (April-June) are potentially vulnerable to the effects of habitat degradation and angling-related mortality and behavioral changes. These data on M. atlanticus phenology provide insights for implementing science-based strategic management plans.
We have conducted flow cytometric studies of two subsets of lymphocyte markers in groups of migraineurs during (n = 12; group B) and outside (n = 10; group C) of a migraine without aura attack (total n = 22; group A), including a group of patients tested in both of these phases (n = 5; group D), and compared these results with those obtained from a population of age-comparable, sex- and race-matched healthy volunteers (n = 12; group E). Comparison of the first set of lymphocytes (CD3+CD16 + 56+, CD3-CD16 + 56+, CD3-CD19+, CD3+CD19+, and CD3+HLA - DR+) between the patients in group A and the controls (group E) showed differences, reflecting greater group A percentages of CD3+CD16 + CD56+ and CD3-CD19+ lymphocytes. Furthermore, these differences reached statistical significance only for the CD3+CD16 + CD56+ lymphocytes, and then solely for the patients in group C (Scheffe's test, p < 0.05). Paired analysis of the above lymphocyte markers for subjects in group D failed to show significant differences between patients when they were having and not having a migraine attack, raising the possibility that results from a larger study could show meaningful increases in percentages of CD3+CD16 + CD56+ lymphocytes as one of the immune parameters useful for differentiating migraineurs from controls. Comparison of a second set of lymphocyte markers (CD19+CD5+, CD20+CD72-, CD20-CD72+, CD20+CD72+) among either the different groups of patients or between the patients and controls failed, however, to show statistically significant differences, emphasizing the apparent specificity of the findings described above for CD3+CD16 + CD56+ lymphocytes. Our results, albeit of a preliminary nature, suggest the occurrence of significant, differential changes in lymphocyte subset immunophenotyping between groups of pain-free migraineurs and patients during an acute migraine episode or controls. Corroboration of these findings may prove useful in clinical laboratory practice to identify changes in immunological parameters specifically associated with migraineurs, and help towards a better understanding of the etiology and pathophysiology of this condition.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.